Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis
Simon Greulich1, Agnes Mayr2, Daniel Kitterer3
1Division of Cardiology, Robert-Bosch-Medical Center Stuttgart, Stuttgart, Germany.
Insights
Rheumatoid arthritis patients show increased myocardial T1, extracellular volume (ECV), and T2 values compared to controls. Cardiovascular magnetic resonance (CMR) mapping aids in assessing cardiac involvement in rheumatoid arthritis.
Area of Science:
- Cardiology
- Radiology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) patients face elevated risks of adverse cardiovascular events.
- Cardiovascular magnetic resonance (CMR) mapping offers advanced myocardial tissue characterization.
- Late gadolinium enhancement (LGE) is a standard CMR technique for assessing myocardial scarring.
Purpose of the Study:
- To evaluate myocardial involvement in RA patients using a multicomponent CMR protocol.
- To assess differences in myocardial tissue characteristics between RA patients and healthy controls.
- To investigate the utility of CMR mapping techniques beyond LGE in RA.
Main Methods:
- Prospective enrollment of 22 RA patients and 20 healthy volunteers.
- Acquisition of CMR including LGE, T1 mapping, and T2 mapping sequences.
- Comparison of myocardial parameters (native T1, ECV, T2 values) between groups.
Main Results:
- RA patients exhibited significantly higher native T1, ECV, and T2 values compared to controls.
- Elevated T2 values showed the most significant difference between RA patients and controls.
- These findings were consistent irrespective of the presence of LGE.
Conclusions:
- Advanced myocardial characterization using CMR mapping reveals subclinical myocardial changes in RA patients.
- T2 mapping is particularly sensitive in detecting myocardial involvement in RA.
- CMR mapping techniques, in addition to LGE, can enhance the evaluation of cardiac involvement in RA.
Objectives:
Rheumatoid arthritis (RA) patients are at increased risk of suffering from adverse cardiovascular events. Cardiovascular magnetic resonance (CMR) mapping techniques might be appropriate tools to complement late gadolinium enhancement (LGE) for the assessment of myocardial involvement. This study aimed to perform advanced myocardial tissue characterisation in RA patients by a multicomponent CMR protocol.
Methods:
22 RA patients were prospectively enrolled and underwent CMR, including LGE and T1/T2 mapping sequences; 20 volunteers served as controls.
Results:
Mean LV-EF was 66%; prevalence of LGE was 18%. RA patients had increased native T1 (985 vs. 959 ms, p = 0.03), expanded extracellular volume (ECV) (27 vs. 25%, p = 0.02) and higher T2 values (52 vs. 49 ms, p < 0.001) compared to controls irrespective of the presence of LGE. T2 mapping showed the highest prevalence of values beyond the 95% percentile of controls.
Conclusion:
RA patients demonstrated higher T1, ECV and T2 values compared to controls, with most significant differences for T2. Since these results seem to be independent of the presence of LGE, advanced myocardial tissue characterisation including CMR mapping techniques in addition to LGE-CMR might be useful in the evaluation of myocardial involvement in RA patients.
Key Points:
• RA patients had higher T1, ECV and T2 values compared to controls. • Most significant differences were observed for T2. • Our results seem to be independent of the presence of LGE. • Mapping might be useful in the evaluation of myocardial involvement in RA.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease I: Introduction
